@kyygirl's hormone therapy day, fact-checked
Quick answer
The creator is a woman receiving subcutaneous testosterone pellet therapy at a direct-to-consumer telehealth clinic, with quarterly monitoring labs and reported symptom improvement including energy and libido. She is self-managing progesterone use based on personal tolerance rather than documented clinical guidance, which raises a concern about unopposed estrogen in the context of her hormone regimen. New-onset acne is a biologically expected androgenic side effect that her provider should be actively monitoring alongside testosterone and estradiol levels.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @kyygirl actually say?
@kyygirl documented her return visit for a testosterone pellet replacement and blood draw at what appears to be a direct-to-consumer telehealth clinic. Her core claims: testosterone pellets are bioidentical, her body only absorbs "what it needs," she avoids weekly injections, and her symptoms of fatigue, low libido, and moodiness resolved after treatment. She also flagged a real side effect: significant new acne.
She mentioned skipping progesterone last cycle because it made her moody, and noted she heard it helps with sleep. Her estrogen was apparently not low per her provider. She's choosing her own supplementation stack around the blood draw, which is worth noting given the timing.
Does the science back this up?
Partly. The symptom picture she described, fatigue, low libido, mood changes, is consistent with female androgen insufficiency, though that diagnosis remains contested in clinical endocrinology. The acne side effect she reported is well-documented and biologically real.
The claim that her body only absorbs "what it needs" from the pellet is not how pellet pharmacokinetics work. Testosterone pellets release hormone through passive diffusion based on surface area, vascularity, and activity level. Your body does not regulate pellet absorption on demand. Testosterone levels from pellets can spike significantly in the first weeks post-insertion and decline over the subsequent months, which is exactly why quarterly blood draws are standard practice. A 2012 study by Glaser and Dimitrakakis in Maturitas documented significant testosterone level variability with pellet therapy in women. There is no known physiological mechanism by which subcutaneous pellets selectively release hormones based on need.
What did they get wrong (or right)?
The self-regulating absorption claim is the biggest factual problem in this video. It sounds reassuring but it is not accurate, and it could give viewers a false sense of safety about pellet therapy. This matters because supraphysiologic testosterone levels in women carry real risks, including irreversible voice deepening and clitoral enlargement, not just acne.
She got the acne connection exactly right. Androgen excess is a primary driver of sebaceous gland activity, and new-onset acne after testosterone initiation is a textbook side effect documented consistently across delivery methods. Park et al. (2019, JAMA Dermatology) confirmed androgenic acne as one of the most common complaints in women receiving testosterone therapy.
The decision to skip progesterone without apparent provider guidance is a clinical flag. In women with a uterus, unopposed estrogen raises endometrial cancer risk, and progesterone's role in that context is protective, not optional. Whether her estrogen levels require concurrent progesterone is a clinical question, not one to self-navigate based on mood preference alone.
What should you actually know?
Female testosterone therapy sits in a complicated regulatory space. The FDA has not approved any testosterone product specifically for women in the US, which means most women receiving it are getting compounded or off-label prescriptions. That is not automatically unsafe, but it does mean the evidence base is thinner than for male hypogonadism treatment.
Pellet therapy specifically has generated concern in the literature around overdosing. A 2020 review by Davis et al. in Climacteric noted that pellets frequently deliver supraphysiologic doses, particularly in the first four to six weeks post-insertion, with no ability to reduce the dose once inserted. Unlike injections or gels, you cannot stop a pellet mid-course if side effects emerge.
Blood draw monitoring every three months is appropriate and should not be skipped. Her provider getting labs before re-dosing is the right call. The concern is whether the interpretation of those labs and the dosing adjustments are being done by a qualified endocrinologist or gynecologist, versus a general wellness clinic optimizing for customer satisfaction.
Bottom line on this video
@kyygirl is sharing a genuine personal experience, and her symptom relief sounds real. The acne disclosure is honest and useful. But the "your body absorbs what it needs" claim is biologically inaccurate and should not be repeated or trusted. Pellet pharmacokinetics do not work that way. Anyone considering pellet therapy should ask their provider specifically about peak testosterone levels post-insertion, not just quarterly averages, and should have a clear conversation about what happens if levels run too high with no easy correction available.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @kyygirl's hormone therapy day, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@kyygirl's hormone therapy day, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator is a woman receiving subcutaneous testosterone pellet therapy at a direct-to-consumer telehealth clinic, with quarterly monitoring labs and reported symptom improvement including energy and libido.
FormBlends verdict
The creator is a woman receiving subcutaneous testosterone pellet therapy at a direct-to-consumer telehealth clinic, with quarterly monitoring labs and reported symptom improvement including energy and libido. She is self-managing progesterone use based on personal tolerance rather than documented clinical guidance, which raises a concern about unopposed estrogen in the context of her hormone regimen. New-onset acne is a biologically expected androgenic side effect that her provider should be actively monitoring alongside testosterone and estradiol levels.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is a woman receiving subcutaneous testosterone pellet therapy at a direct-to-consumer telehealth clinic, with quarterly monitoring labs and reported symptom improvement including energy and libido. She is self-managing progesterone use based on personal tolerance rather than documented clinical guidance, which raises a concern about unopposed estrogen in the context of her hormone regimen. New-onset acne is a biologically expected androgenic side effect that her provider should be actively monitoring alongside testosterone and estradiol levels.
- Testosterone pellets do not self-regulate based on the body's needs. Release is driven by passive diffusion and physical activity level, meaning supraphysiologic spikes in the first 4-6 weeks post-insertion are common and documented (Davis et al., 2020, Climacteric).
- No FDA-approved testosterone product exists specifically for women in the US. Women receiving pellet therapy are getting compounded or off-label prescriptions, which are legal but carry a thinner evidence base than male hypogonadism treatments.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone pellets do not self-regulate based on the body's needs. Release is driven by passive diffusion and physical activity level, meaning supraphysiologic spikes in the first 4-6 weeks post-insertion are common and documented (Davis et al., 2020, Climacteric).
- No FDA-approved testosterone product exists specifically for women in the US. Women receiving pellet therapy are getting compounded or off-label prescriptions, which are legal but carry a thinner evidence base than male hypogonadism treatments.
- New-onset acne after starting testosterone is a predictable androgenic side effect, not a sign the dose is wrong or right. It indicates androgen activity at the sebaceous gland level and warrants monitoring, not just a skincare routine.
- Pellet therapy cannot be reversed mid-course. Unlike injections or gels, once a pellet is inserted, dose reduction is not possible if levels run too high or side effects become severe. This is a meaningful practical risk patients should understand before choosing this delivery method.
- Progesterone decisions in women with a uterus who are on hormone therapy should be guided by endometrial safety considerations, not mood tolerance alone. Unopposed estrogen exposure increases endometrial cancer risk regardless of testosterone status.
- Quarterly blood draws before re-dosing are the appropriate standard of care for pellet therapy monitoring. The creator's clinic following this protocol is clinically appropriate, though what matters equally is who interprets the results and how dosing decisions are made.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Kyygirl · TikTok creator
8.3K views on this video
Hormone therapy #dayinthelife
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Kyygirl, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.